Pluristem Reports Preliminary Data from its COVID-19 Compassionate Use Program, Treating Seven Patients withAcute Respiratory Failure

Pluristem Reports Preliminary Data from its COVID-19 Compassionate Use Program, Treating Seven Patients withAcute Respiratory Failure. All treated patients were in Intensive Care Units...

Read more

Pluristem (Israel) Signs MOU for Collaboration with Fukushima Medical University to Study PLX-R18 in Acute Radiation Syndrome

Pluristem Therapeutics Inc. a leading developer of placenta-based cell therapy products, has signed a Memorandum of Understanding (MOU) for a collaboration withFukushima Medical University,...

Read more

Israël Science Info